Introduction {#s1}
============

Birth defects (BDs) or congenital anomalies are defined as a series of structural, functional, or metabolic disorders during the development of the embryo or fetus ([@B1]). BDs have caused early miscarriage, fetal death, infant death, childhood disabilities, and have been a global public health issue ([@B2]). It was estimated that the incidence rate of BDs in low-income, developing, and developed countries were 64.2, 55.7, and 47.2 per 1,000 live births, respectively ([@B3]). In China, 5.6% of total newborns were born with BDs annually, about the level of developing countries ([@B4]). The prevalence rates of different BDs have changed immensely in the last few decades ([@B4]). Specially, the incidence rates of limb reduction and neural tube defect (NTD) declined tremendously ([@B5]), while the prevalence rate of CHD was found to show an increasing trend globally ([@B6]). Most BDs arise from a complex and ill-defined combination of genetic and environmental factors ([@B7]). There are palpable regional differences in the prevalence of BDs for the fact that risk factor varies widely with time and place. In order to identify the incidence, trends and risk factors of BDs, it is crucial to study their epidemiology.

There are two types of national surveillance systems in China, namely, hospital-based surveillance system (including early fetuses \<28 weeks of gestation and perinatal infants between 28 weeks of gestation and 7 days after birth born in hospitals) and population-based surveillance system (including dead fetus, stillbirth, terminations of pregnancy, and live birth between 28 weeks of gestation and 42 days postpartum birth lived in particular districts or counties). It is incomparable to the data in these two systems for different coverage of surveillance time quantum. Several articles reported the epidemiology of BDs in hospital-based surveillance system, but few described the prevalence of BDs in population-based surveillance system. Therefore, reporting the population-based prevalence of BDs is also necessary.

Tianning District is located in the economically developed Taihu Plain of the Yangtze River Delta. Its traffic is convenient and it attracted many migrants. It has diversified industries, with textile-clothing and machanical-electronic as the pillars. Industrial environmental risk factors such as noise have brought challenges to the prevention of adverse pregnancy outcomes ([@B8]). Tianning District has become one of the population-based surveillance spots of BDs in China since 2006. In 2018, the monitoring data showed that the prevalence of BDs increased remarkably. In this study, we aimed to describe the epidemiology and characteristics of BDs in Tianning District between 2014 and 2018.

Methods {#s2}
=======

Study Population
----------------

The study population included live birth, stillbirth, dead fetus, and legal termination of pregnancy between 28 weeks gestation and 42 days postpartum whose mother lived in Tianning District between 2014 and 2018. The study has complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research and was approved by the Ethics Committee of Changzhou Maternity and Child Health Care Hospital affiliated to Nanjing Medical University. Participants consented were achieved when community doctors visited parturients 42 days after their delivery.

Data Collection and Quality Control
-----------------------------------

According to "Maternal and Child Health Monitoring Manual in China" formulated by the National Office for Maternal and Child Health Surveillance of China, diseases numbered Q00.000-Q99.999 or O35.000-35.206 in the International Classification of Diseases Clinical Modification Codes, 10th revision (ICD-10) were noted as birth defects should be monitored in our surveillance system ([@B4]). External birth defects were diagnosed with physical examination, visceral anomalies were mainly diagnosed with ultrasonography or ray examination, and chromosomal or genetic diseases were diagnosed with molecular diagnostic methods. The criteria of BDs diagnosis has been stable since 2003 according to "Maternal and Child Health Monitoring Manual in China." Professional and trained obstetric or pediatric health care doctors from Community Health Service Centers of Tianning District collected information from parents of birth defect cases and hospitals, and filled the "Birth Defects Registration Form" of every case and "Follow-up Registration Form" of each perinatal infant. Obstetric health care doctors of Tianning Maternal and Child Health Family Planning Service Center input the information to the surveillance system. Information was audited by maternity and child health care hospitals and health administrative departments, respectively. Quality control of the data were conducted quarterly at district-level, half-yearly at city-level, and yearly at province-level or nation-level to ensure the accuracy of relevant information.

Statistical Analysis
--------------------

Poisson distribution and poisson regression were performed to calculate the prevalence rates, potential risk factors and adverse consequences of BDs ([@B4]). R version 3.5.1 (The Comprehensive R Archive Network: <http://cran.r-project.org>) was used for data statistical analysis. *P* \< 0.05 was considered as representative of statistically significant.

Results {#s3}
=======

Annually prevalence rates and trends of total BDs in Tianning District from 2014 to 2018 are summarized in [Table 1](#T1){ref-type="table"}. From 2014 to 2018, 28,040 infants were registered and 436 BDs were diagnosed in Tianning District, resulting in an incidence of 155.49 (95% CI: 141.24--170.80) per 10,000 infants. Although poisson regression showed no significant increase in the prevalence rates of total BDs during the 5-year study period, the prevalence rates of BDs in 2018 was much higher than those in the other years.

###### 

Prevalence rates and trends of BDs in Tianning District, 2014--2018.

  **Year**   **BDs[^**\***^](#TN1){ref-type="table-fn"}(n)**   **Infants(n)**   **Prevalences of BDs per 10,000 infants (95% CI)**   **PRR[^**\#**^](#TN2){ref-type="table-fn"}(95% CI)**
  ---------- ------------------------------------------------- ---------------- ---------------------------------------------------- ------------------------------------------------------
  2014       71                                                4,671            152.00 (118.71, 191.73)                              1.05 (0.98, 1.12)
  2015       70                                                4,608            151.91 (118.42, 191.93)                              
  2016       96                                                6,842            140.31 (113.65, 171.34)                              
  2017       94                                                6,309            148.99 (120.40, 182.33)                              
  2018       105                                               5,610            187.17 (153.08, 226.58)                              
  Total      436                                               28,040           155.49 (141.24, 170.80)                              /

*BDs, birth defects*.

*PRR, prevalence rate ratio*.

As shown in [Table 2](#T2){ref-type="table"}, during the study period, BDs in circulatory, musculoskeletal, urogenital and digestive systems were more common. Particularly, the 10 most common BDs were CHD, polydactyly, congenital malformation of kidney(CMK), syndactyly, cleft palate, hypospadias, congenital hypothyroidism(CH), congenital atresia of rectum and anus, congenital talipes equinovarus(CTE), and microtia, with incidence rates of 124.11, 19.61, 8.56, 6.42, 4.64, 4.64, 4.28, 4.28, 3.57, and 3.57 per 10,000 infants, respectively. The prevalence rate of CHD (PRR 1.191, 1.099--1.290) increased significantly from 2014 to 2018. Other BDs remained stable through the study period.

###### 

Prevalence rates and trends of selected BDs in Tianning District, 2014--2018 (per 10,000 infants).

  **Types of BDs[^**\***^](#TN3){ref-type="table-fn"}**   **2014**   **2015**   **2016**   **2017**   **2018**   **Total**   **Rank**   **PRR[^**\#**^](#TN4){ref-type="table-fn"}(95% CI)**
  ------------------------------------------------------- ---------- ---------- ---------- ---------- ---------- ----------- ---------- -----------------------------------------------------------
  **Central nervous system**                                                                                                            
  Subependymal cysts                                      2.14       2.17       0          0          1.78       1.07        14         0.78 (0.34, 1.81)
  **Eye, ear, face, and neck**                                                                                                          
  Microtia                                                4.28       4.34       4.38       3.17       1.78       3.57        7          0.84 (0.53, 1.32)
  Other malformation of external ear                      4.28       4.34       2.92       0          3.57       2.85        9          0.82 (0.49, 1.36)
  **Lip, plate**                                                                                                                        
  Cleft palate                                            6.42       4.34       5.85       1.59       5.35       4.64        5          0.89 (0.60, 1.33)
  Cleft lip                                               2.14       2.17       5.85       3.17       1.78       3.21        8          0.99 (0.61, 1.60)
  Cleft lip and palate                                    4.28       0          0          1.59       3.57       1.78        12         1.04 (0.54, 1.99)
  **Circulatory system**                                                                                                                
  Congenital heart defects                                107.07     97.66      86.23      142.65     185.38     124.11      1          **1.19 (1.10, 1.29)**[^**a**^](#TN5){ref-type="table-fn"}
  **Digestive system**                                                                                                                  
  Congenital atresia of rectum and anus                   4.28       10.85      4.38       0          3.57       4.28        6          0.74 (0.49, 1.14)
  Congenital gastric volvulus                             2.14       0          1.46       0          3.57       2.50        10         1.41 (0.77, 2.57)
  Congenital atresia of intestine                         4.28       2.17       0          0          1.78       2.14        11         0.61 (0.28, 1.33)
  Congenital pyloristenosis                               6.42       2.17       1.46       0          1.78       2.14        11         0.58 (0.30, 1.11)
  Gastrointestinal obstruction                            2.14       4.34       0          1.59       0          1.43        13         0.61 (0.28, 1.33)
  Congenital esophageal atresia                           4.28       0          0          1.59       0          1.07        14         0.51 (0.19, 1.37)
  **Urogenital system**                                                                                                                 
  Congenital malformation of kidney                       10.70      6.51       14.62      3.17       7.13       8.56        3          0.87 (0.65, 1.17)
  Hypospadias                                             8.56       6.51       2.92       3.17       3.57       4.64        5          0.76 (0.50, 1.14)
  Cryptorchidism                                          0          0          1.46       1.59       1.78       1.07        14         1.73 (0.63, 4.78)
  **Musculoskeletal system**                                                                                                            
  Polydactyly                                             19.27      17.36      24.85      17.44      17.83      19.61       2          0.98 (0.81, 1.19)
  Syndactyly                                              6.42       2.17       11.69      7.93       1.78       6.42        4          0.93 (0.67, 1.31)
  Congenital talipes equinovarus                          4.28       0          2.92       4.76       5.35       3.57        7          1.23 (0.76, 1.99)
  Umbilical hernia                                        0          6.51       1.46       1.59       1.78       2.14        11         1.55 (0.83, 2.91)
  Congenital diaphragmatic hernia                         0          0          2.92       1.59       0          1.07        14         1.12 (0.48, 2.62)
  **Endocrine system**                                                                                                                  
  Congenital hypothyroidism                               2.14       4.34       2.92       6.34       5.35       4.28        6          1.23 (0.80, 1.91)
  **Chromosomal abnormalities**                                                                                                         
  Down\'s syndrome                                        0          2.17       1.46       1.59       0          1.07        14         0.93 (0.41, 2.14)
  **Other**                                                                                                                             
  Hemangioma                                              0          2.17       2.92       1.59       5.35       2.50        10         1.55 (0.83, 2.91)

*BDs, birth defects*.

*PRR, prevalence rate ratio*.

*The prevalence of CHD increased by 19.00% per year on average during the study period*.

The incidence rates of different infant gender, five maternal age groups, different gravidity and parity as well as results of poisson regression are summarized in [Table 3](#T3){ref-type="table"}. The prevalence rate of BDs in women with gravidity ≥ 3 was significantly higher than that in women with gravidity = 1 (194.38 vs. 140.51 per 10,000 infants, PRR = 1.38, 95% CI: 1.09--1.75). After adjusting for maternal age, this association still existed (adjusted PRR = 1.52, 95% CI: 1.18--1.96). The incidence rate of BDs in multiple births was significantly higher than that in singleton births (426.36 vs. 147.82 per 10,000 infants, PRR = 2.88, 95% CI: 2.02--4.11). Moreover, as shown in [Table 3](#T3){ref-type="table"}, infants with BDs were more likely to become premature infants (PRR = 4.29, 95% CI: 3.39--5.44), fetal death or stillbirths (PRR = 24.79, 95% CI: 16.42--37.43), and infant death (PRR = 43.19, 95% CI: 27.56--67.69). However, we did not detect significant differences on prevalence of BDs between infant gender groups or maternal age groups.

###### 

Prevalence rates of BDs analyzed from the perspective perinatal characteristics.

  **Characteristics**   **BDs[^**\***^](#TN6){ref-type="table-fn"}(n)**   **Infants(n)**   **Prevalences of BDs per 10,000 infants (95% CI)**   **PRR[^**\#**^](#TN7){ref-type="table-fn"}(95% CI)**   
  --------------------- ------------------------------------------------- ---------------- ---------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------------
  Infant gender         Male                                              245              14,603                                               167.77 (147.42, 190.15)                                1.18 (0.98, 1.43)
                        Female                                            191              13,437                                               142.14 (122.70, 163.80)                                Reference
  Maternal age          \<20                                              5                327                                                  152.91 (49.65, 356.83)                                 0.99 (0.41, 2.39)
                        20--24                                            69               3,933                                                175.44 (136.50, 222.03)                                1.13 (0.86, 1.48)
                        25--29                                            209              13,473                                               155.13 (134.81, 177.64)                                Reference
                        30\~34                                            110              7,042                                                156.21 (128.38, 188.27)                                1.01 (0.80, 1.27)
                        35\~                                              43               3,258                                                131.98 (95.52, 177.78)                                 0.85 (0.61, 1.18)
  Gravidity             1                                                 187              13,309                                               140.51 (121.09, 162.15)                                Reference
                        2                                                 137              8,531                                                160.59 (134.83, 189.84)                                1.14 (0.92, 1.42)
                        ≥3                                                112              5,762                                                194.38 (160.05, 233.89)                                **1.38 (1.09, 1.75)**[^**a**^](#TN8){ref-type="table-fn"}
  Type of pregnancy     Multiple                                          33               774                                                  426.36 (293.48, 598.76)                                **2.88 (2.02, 4.11)**[^**b**^](#TN9){ref-type="table-fn"}
                        Singleton                                         403              27,262                                               147.82 (133.74, 162.99)                                Reference
  Premature delivery    Yes                                               86               1,518                                                566.53 (453.15, 699.67)                                **4.29 (3.39, 5.44)**[^**c**^](#TN10){ref-type="table-fn"}
                        No                                                350              26,522                                               131.97 (118.50, 146.54)                                Reference
  Birth outcome         Stillbirth and fetal death                        24               69                                                   3,478.26 (2,228.59, 5,175.38)                          **24.79 (16.42, 37.43)**[^**d**^](#TN11){ref-type="table-fn"}
                        Infant death                                      20               33                                                   6,060.61 (3,701.98, 9,360.12)                          **43.19 (27.56, 67.69)**^**d**^
                        Live birth                                        392              27,937                                               140.32 (126.77, 154.92)                                Reference

*BDs, birth defects*.

*PRR, prevalence rate ratio*.

*The risk of BDs in infants delivered by women with gravidity ≥ 3 was 1.38 times higher than those delivered by women with gravidity = 1*.

*The risk of BDs in multiparity was 2.88 times higher than those in single pregnancy*.

*The risk of BDs in premature infants was 4.29 times higher than those in term infants*.

*The risk of BDs in still birth and fetal death was 24.79 times higher than those in live birth. The risk of BDs in infant death was 43.19 times higher than those in live birth*.

Discussion {#s4}
==========

In the current study, we detected significant increase in the prevalence of CHD with a PRR of 1.191. BDs in circulatory, musculoskeletal, urogenital and digestive systems were more common. Gravidity ≥ 3 and multiple births were risk factors for occurrence of BDs, and premature delivery, fetal death or stillbirth, and infant death were adverse consequences of BDs.

In our study, 24.31 percent (106/436) infants with BDs were found between 8 days and 42 days after their birth. Also, with the advancing of diagnosis skills, many BDs can be found before 28 weeks of gestation and pregnant women with severe BDs might choose the termination of pregnancy ([@B9]). Expanding time quantum of surveillance and collecting information of women with severe BDs choosing termination \<28 weeks of gestation are necessary to get an exact disease spectrum of BDs so as to make better prevention strategy. Besides, circulatory, musculoskeletal, urogenital and digestive systems were susceptible to BDs and more attention should be paid to them.

The prevalence of CHD was the highest among all kinds of BDs during the study period. Moreover, it varied between 86.23/10,000 and 185.38/10,000. An European study revealed that the incidence rates of CHD had increased 9 times in recent decades ([@B6]). The increase in CHD incidence over time is caused by advance in diagnostic means such as better, more normative and accessible perinatal B-mode ultrasonography services ([@B10]--[@B12]). Also, potential risk factors including environmental pollution such as specific combustion pollutants, occupational hazards, and mental stress could influence the prevalence of CHD ([@B8], [@B13]). As its serious hazards to sick infants and children, much attention should be paid to the prevention and screening of CHD. Avoiding exposure to environmental and occupational hazards during early pregnancy, joyful mood, and regular perinatal examination are effective measures.

We found that CMK and hypospadias were the third and fifth highest among all kinds of BDs, which is a little higher than the rank of Hunan Province ([@B14]). Urinary malformations are caused by complex interactions between genetic and environmental factors, some of which have been identified ([@B15]). It is suggested that maternal obesity, diabetes, kidney disease, low birth weight, smoking and drinking during pregnancy result in urinary anomalies ([@B16]--[@B19]). Moreover, other studies have suggested that environmental pollutants such as chlorination disinfection byproduct in drinking water, TCDD (2,3,7,8-tetracholrodibenzo-p-dioxin), endocrine disrupting chemicals (EDCs) are associated with occurrence of CMK or hypospadias ([@B20]--[@B22]). Therefore, building up a healthy life style, avoiding exposure to environmental pollutants, and paying attention to protection at work are important measures to cut down the prevalence rates of CMK and hypospadias.

Cleft palate was the fifth highest among all types of BDs in our study. It is estimated that cleft palate affecting 1--25 per 10,000 newborns worldwide ([@B23]). The potential risk factors for cleft palate have been extensively researched through epidemiologic and experimental studies, which included maternal exposure to tobacco smoke, alcohol, and corticosteroids; folic acid deficiency; zinc deficiency; maternal grief; paternal advanced age; and paternal smoking or alcohol use ([@B24]--[@B30]). Gene- environment interactions such as potential interaction between *TBX4* (chromosome17q21-q22) and dietary folate might also contribute to the occurrence of cleft palate ([@B31]). Therefore, smoking cessation, limited alcohol, balanced nutrition, joyful mood, pregnancy at appropriate age, and improving the technology of prenatal diagnosis are crucial for the prevention of cleft palate.

CH was the sixth highest among all kinds of BDs in our study. CH is a common endocrine disease in newborns and affects \~1 in 2,000--4,000 live births ([@B32]). According to the national network of neonatal screening centers, the average prevalence of CH in China was 1 per 2,047 between 1985 and 2007, and the prevalence rate increased significantly during the study period ([@B33]). Multiple factors including ethnicity, characteristics of birth and pregnancy, and screening programs associate with the occurrence of CH ([@B34]). The most common clinical features of CH were delayed physiological development, constipation, jaundice, and intellectual disability ([@B35]). Fortunately, CH could be controlled at steady status by early detection and timely treatment, and neonatal screening is an sensitive measure to detect CH. Popularizing neonatal screening, following up and managing CH cases effectively are necessary to guarantee the life quality of CH cases.

The authors found that women with gravidity ≥3 were more likely to give birth to infants with BDs, and after adjusting for maternal age, this association still remained. Li et al. reported that gravidity was associated with occurrence of CHD ([@B13]). In general, the increase of gravidity indicates the increase of accidental pregnancy, unwanted pregnancy, and termination of pregnancy, which were risk factors of high-risk births ([@B35]). So it is necessary to take effective contraception measures and provide birth health counseling. Besides, multiple births were risk factors for occurrence of BDs. In order to cut down the birth rate of severe BDs, perinatal examination for multiple births should be more careful. In addition, similar to Kancherla\'s study, premature delivery, fetal death or stillbirth, and infant death were adverse consequences of BDs ([@B2]). However, we did not detect significant association between infant gender and BDs, which is different from Xie\'s study ([@B14]). Although males are more susceptible to BDs for Y chromosome and their external genital malformations are more detectable ([@B36], [@B37]), with the expansion of surveillance time quantum, several genital deformities can be diagnosed in female infants. Moreover, some BDs mostly diagnosed after birth such as cleft palate and CH are more often in female infants ([@B23], [@B34]). Besides, some studies reported that maternal age had association with occurrence of BDs ([@B14], [@B38]), but we did not detect the association in the present study. The probable reasons are as follows: on the one hand, the authors were underpowered to detect differences between maternal age and BDs because of small sample sizes of pregnant women younger than 20 or older than 35; on the other hand, pregnant women younger than 20 tend to choose the termination of pregnancy at small gestational age for not being allowed to get married, so do pregnant women older than 35 for serious BDs such as chromosome aberration ([@B39]). Thus, the impact of infant gender and maternal age on BDs needs further research.

Limitations {#s5}
===========

There are several limitations in our study. First, different types of BDs have different causes and pathogenesis, it is better to collect information on risk factors including genetic and environmental elements of BDs, and report the association between risk factors and BDs individually. Second, without materials concerning termination at small gestational age in pregnant women with serious BDs could underestimate the incidence rate of BDs. Third, the study is limited by the size of the study population. Pooling data from several national population-based birth defect surveillance regions can get more meaningful results.

Conclusions {#s6}
===========

In summary, a significant increase in the prevalence of CHD was detected from 2014 to 2018 in Tianning District. Gravidity ≥ 3 and multiple births were risk factors for occurrence of BDs. Besides, infants with BDs were more likely to become premature infants, fetal death or stillbirths, and infant death. In order to make more targeted prevention strategy, we need to expand surveillance time quantum of BD surveillance system and collect risk factors associated with BDs. Besides, strengthening health education on birth health counseling, regular perinatal examination and improving the skill of diagnosis and monitoring are crucial to lower the incidence of BDs.
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